Celltrion

Ultime notizie

Titoli nella lingua originale della fonte.

• Celltrion obtains U.S. Phase 3 clinical trial approval for ‘Zymfentra’ seeking expansion for rheumatoid arthritis indications (si apre in una nuova scheda)

  더바이오 · 2 ott 2026

• Celltrion to Expand Global Supply Chain and CDMO Partnerships at CPHI, Accelerating Push to Become Global Drugmaker (si apre in una nuova scheda)

  v.daum.net · 29 set 2026

• Celltrion wins U.S. Phase 3 clinical trial approval for ‘Zymfentra’ in rheumatoid arthritis, expanding indications (si apre in una nuova scheda)

  더바이오 · 27 set 2026

• How Celltrion's Remsima Became Japan's Top Infliximab: A 2026 Market Analysis (si apre in una nuova scheda)

  뉴스1 · 18 set 2026

• Celltrion Submits U.S. Phase 4 IND for High-Dose 240 mg Zymfentra (si apre in una nuova scheda)

  뉴스1 · 16 set 2026

• Celltrion Launches U.S. Phase 4 Trial of High-Dose Zymfentra (si apre in una nuova scheda)

  팜이데일리 · 15 set 2026

• “Second-Half Performance to Outpace First Half”… Celltrion Expected to Exceed Full-Year Revenue Target (si apre in una nuova scheda)

  뉴스1 · 4 set 2026